Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionBoston Research & Management Inc
Latest Disclosed Ownership1,237 shares
Latest Disclosed Value $ 435
Boston Research & Management Inc ownership in AMGN / Amgen Inc.

On April 10, 2026 - Boston Research & Management Inc filed a 13F-HR form disclosing ownership of 1,237 shares of Amgen Inc. (MX:AMGN) valued at $435 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,237 shares of Amgen Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F Amgen COM 031162100 1,237 0 0.00 0 0.1033
2026-02-11 2025-12-31 13F Amgen COM 031162100 1,237 0 0.00 0 0.0932
2025-11-12 2025-09-30 13F Amgen COM 031162100 1,237 0 0.00 0 0.0770
2025-08-12 2025-06-30 13F Amgen COM 031162100 1,237 0 0.00 0 0.0825
2025-05-12 2025-03-31 13F Amgen COM 031162100 1,237 0 0.00 0 0.0956
2025-02-12 2024-12-31 13F Amgen COM 031162100 1,237 0 0.00 0 0.0790
2024-11-12 2024-09-30 13F Amgen COM 031162100 1,237 0 0.00 0 0.0935
2024-08-13 2024-06-30 13F Amgen COM 031162100 1,237 0 0.00 0 0.0976
2024-05-14 2024-03-31 13F Amgen COM 031162100 1,237 0 0.00 0 0.0868
2024-02-12 2023-12-31 13F Amgen COM 031162100 1,237 0 0.00 0 0.0945
2023-11-13 2023-09-30 13F Amgen COM 031162100 1,237 0 0.00 0 0.0981
2023-08-01 2023-06-30 13F Amgen COM 031162100 1,237 50 4.21 0 0.0776
2023-05-10 2023-03-31 13F Amgen COM 031162100 1,187 0 0.00 0 0.0854
2023-02-13 2022-12-31 13F Amgen COM 031162100 1,187 0 0.00 0 -100.00 0.0962
2022-11-14 2022-09-30 13F Amgen COM 031162100 1,187 0 0.00 267 -7.29 0.0910
2022-08-11 2022-06-30 13F Amgen COM 031162100 1,187 0 0.00 288 0.35 0.0933
2022-05-12 2022-03-31 13F Amgen COM 031162100 1,187 0 0.00 287 7.49 0.0833
2022-02-10 2021-12-31 13F Amgen COM 031162100 1,187 0 0.00 267 5.95 0.0729
2021-11-10 2021-09-30 13F/A-1 Amgen COM 031162100 1,187 0 0.00 252 -12.80 0.0750
2021-11-10 2021-09-30 13F Amgen COM 031162100 1,187 0 295 0.0950
2021-08-11 2021-06-30 13F Amgen COM 031162100 1,187 0 0.00 289 -2.03 0.0877
2021-05-11 2021-03-31 13F Amgen COM 031162100 1,187 7 0.59 295 8.86 0.0950
2021-02-09 2020-12-31 13F Amgen COM 031162100 1,180 0 0.00 271 -9.36 0.0943
2020-11-09 2020-09-30 13F Amgen COM 031162100 1,180 0 0.00 299 7.55 0.1169
2020-08-10 2020-06-30 13F Amgen COM 031162100 1,180 0 0.00 278 16.32 0.1155
2020-05-08 2020-03-31 13F Amgen COM 031162100 1,180 0 0.00 239 -15.85 0.1200
2020-02-07 2019-12-31 13F Amgen COM 031162100 1,180 0 0.00 284 24.56 0.1065
2019-11-12 2019-09-30 13F Amgen COM 031162100 1,180 0 0.00 228 5.07 0.0902
2019-08-07 2019-06-30 13F Amgen COM 031162100 1,180 0 0.00 217 -3.12 0.0878
2019-05-07 2019-03-31 13F Amgen COM 031162100 1,180 0 0.00 224 -2.18 0.0933
2019-02-06 2018-12-31 13F Amgen COM 031162100 1,180 0 0.00 229 -6.15 0.1090
2018-11-13 2018-09-30 13F Amgen COM 031162100 1,180 -160 -11.94 244 -1.21 0.1115
2018-07-30 2018-06-30 13F Amgen COM 031162100 1,340 160 13.56 247 22.89 0.1216
2018-05-09 2018-03-31 13F Amgen COM 031162100 1,180 0 0.00 201 -1.95 0.1024
2018-02-09 2017-12-31 13F Amgen COM 031162100 1,180 0 0.00 205 -6.82 0.1028
2017-11-09 2017-09-30 13F Amgen COM 031162100 1,180 0 0.00 220 8.37 0.1124
2017-08-08 2017-06-30 13F Amgen COM 031162100 1,180 1,180 203 0.1098
2015-05-11 2015-03-31 13F Amgen COM 031162100 0 -1,380 -100.00 0 -100.00
2015-02-11 2014-12-31 13F Amgen COM 031162100 1,380 -300 -17.86 219 -6.81 0.1373
2014-11-04 2014-09-30 13F Amgen COM 031162100 1,680 0 0.00 235 13.53 0.1580
2014-05-13 2014-03-31 13F Amgen COM 031162100 1,680 1,680 207 0.1522
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.